Abstract:Background SAPHO syndrome is a rare disease with the typical involvement of the anterior chest wall. The spinal involvement is more often than we thought and less understood by us. Objectives To assess the clinical and imaging features of the spinal involvement in SAPHO syndrome. Methods Patients diagnosed with SAPHO syndrome in Peking University Third Hospital from 2006 to 2018 were recruited. Patients were divided into spinal involvement group and non-spinal involvement group. Patients with AS (ankylosing spondylitis) were recruited as control group. Their clinical data, laboratory data and imaging data (CT, MRI and radionuclide imaging) were collected and were conpared. All the patients with SAPHO syndrome were followed up regularly. Results Totally 46 SAPHO patients were included (17 male and 29 female) and 34 patients (73.9%) had spinal involvement. The mean age was 50.2±10.9 years and the mean disease duration was 5.4±6.4 years. 50 patients with AS were also included. Compared with non-spinal involvement group, the age at disease onset in spinal involvement group was older, the disease duration was longer,t;he CRP elevation was more often and the anterior chest wall involvement was less often (table 1). In spinal involvement group, the thoracic spine was most commonly involved and the vertebral inflammatory changes including bone marrow edema were often seen. These patients were more likely to suffer from cervical spine involvement, endplate inflammation and spondyldiscitis (table 2).Abstract AB1081 Table 1 characteristics of SAPHO syndrome patients with and without spinal involvement characteristics Spinal involvement (n=34) Non-spinal involvement (n=12) P value Sex, female 21(61.8%) 8(36.7%) NS Age at diagnosis, yrs 52.2±10.3 44.6±10.6 0.033* Disease duration, yrs 6.1±7.1 3.1±2.4 0.048* Dermatological disorders 19(55.9%) 10(83.3%) NS CRP elevated 21 (4.6±12.1) 4 (3.0±4.3) 0.047* ESR elevated 16 (31.2±24.0) 6 (32.2±27.2) NS TNF-αelevated 12 (58.6±55.9) 13 (45.3±22.7) NS IL-6 elevated 18 (320.5±343.9) 42 (48.6±328.2) NS sternoclavicular 18 12 0.003* Clavicle 6 2 NS First rib 8 5 NS Sternocostal joint 6 2 NS Sternum corner 1 3 0.02* Manubrium 6 0 NS Sacroiliac joint 6 5 NSAbstract AB1081 Table 2 characteristics of SAPHO syndrome and AS patients with spinal involvement characteristics SAPHO (n=34) AS (n=50) P value Sex, female 21(61.8%) 17(34.0%) 0.012* Age at onset, yrs 52.2±10.3 35.4±12.0 0.0008* Disease duration, yrs 6.1±7.1 7.4±7.3 NS CRP elevated 16(4.6±12.1) 26 (2.11±2.52) NS ESR elevated 16 (31.2±24.0) 18 (28.4±24.6) NS HLA-B27 positive 1(2.9%) 48(96.0%) 0.000* Cervical vertebra 17(50.0%) 13(26.0%) 0.024* Thoracic vertebra 22(64.7%) 33(66.0%) NS Lumbar vertebra 17(50%) 34(68.0%) NS Contiguous/multiple vertebra involvement 28(82.4%) 50(100%) 0.002* Vertebral inflammation 34(100%) 48(96.0%) NS Endplate inflammation 8(23.5%) 3(6.0%) 0.019* Spondylodiscitis 16(47.1%) 4(8.0%) 0.001* Vertebral body corner involvement 11(32.4%) 13(26.0%) NS Paravertebral ossification 4(11.8%) 5(10.0%) NS All the SAPHO patients with spinal involvement were followed up. 30 patients received NSAIDs plus DMARDS/biologics and the symptoms improved. Reexamined imaging data of 10 patients were available and the spinal involvement became better. Conclusion 73.9% of SAPHO patients had spinal involvement and they were more likely to suffer from cervical spine involvement, endplate inflammation and spondyldiscitis. The combination of NSAIDS and biologics/DMARDs were helpful to improve the symptoms. References [1] Mcgauvran A M, Kotsenas A L, Diehn F E, et al. SAPHO Syndrome: Imaging Findings of Vertebral Involvement.[J]. Ajnr Am J Neuroradiol, 2016, 37(8). Acknowledgement This study was supported by a Project of the National Natural Science Foundation of China (81501390). Disclosure of Interests None declared

68Ga-DOTA-FAPI-04 PET/CT Imaging in a Case of SAPHO Syndrome

Comparison of 68Ga-DOTA-FAPI-04 and 18F-FDG PET/CT in Patients With SAPHO Syndrome

Prospective Comparison of the Imaging Value of 99m Tc-MDP Bone Scan and 68 Ga-FAPI-04 PET/CT in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome

Diffuse Uptake of 68Ga-Pentixafor in the Breasts During the Ovulatory Phase in a Patient with SAPHO Syndrome.

99Tcm-MDP whole body bone imaging in 25 patients with SAPHO syndrome

Relapse of Low Back Pain after Internal Lumbar Fixation Was Diagnosed with SAPHO Syndrome: A Case Report.

68Ga-FAPI-04 PET/CT Imaging in a Patient With Psoriatic Arthritis

Clinical and Imaging Features of Six Han Patients with SAPHO Syndrome

18F-FAPI PET/CT Imaging in a Case of Synovial Sarcoma

99Tcm-MDP联合18F-FDG显像辅助诊断SAPHO综合征一例

18 F-FAPI PET/CT Imaging in a Case of Synovial Sarcoma

Increased 18F-FAPI uptake in bones and joints of lung cancer patients: characteristics and distributions

The challenging diagnosis of synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome: A rare case report

Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis (SAPHO) Syndrome Mimicking Bone Metastases in the Spine: A Presentation of Two Cases and Literature Review

Imaging Characteristics Of Adult Onset Still'S Disease Demonstrated With F-18-Fdg Pet/Ct

In Vivo Fibroblast Activation of Systemic Sarcoidosis: A 68Ga-FAPI-04 PET/CT Imaging Study

Clinical and Radiological Identification and Management of SAPHO Syndrome

Pleural Spindle Cell Sarcoma on 68 Ga-DOTA-FAPI-04 PET/CT and 18 F-FDG PET/CT : A Rare Case

Pleural Spindle Cell Sarcoma on 68Ga-Dota-fapi-04 PET/CT and 18F-FDG PET/CT

The Clinical Characteristics and Prognosis of Patients with SAPHO Syndrome--a Real-World Cohort Study.

AB1081 A COMPARATIVE STUDY ON THE FEATURES OF THE SPINAL INVOLVEMENT IN SAPHO SYNDROME